Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akari Therapeutics PLC (NASDAQ:AKTX)

16.56
Delayed Data
As of 12:26pm ET
 -0.54 / -3.13%
Today’s Change
4.00
Today|||52-Week Range
46.70
+14.24%
Year-to-Date
No recent news for Akari Therapeutics PLC.

Today’s Trading

Previous close17.10
Today’s open17.65
Day’s range15.86 - 17.65
Volume4,622
Average volume (3 months)8,850
Market cap$200.5M
Dividend yield--
Data as of 12:26pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)-5.76%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.98

Competitors

 Today’s
change
Today’s
% change
OSIROsiris Therapeutics ...-0.33-5.74%
ENZYEnzymotec Ltd-0.11-1.26%
SZYMSolazyme Inc0.000.00%
PFNXPfenex Inc+0.28+3.49%
Data as of 1:09pm ET, 05/03/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$9.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO, Director, Head-Investor &
Media Relations
Gur A. Roshwalb
Chief Operating Officer &
Director
Clive Richardson
Corporate headquarters
London, Greater London

Forecasts

Partner Offers

Search for Jobs